Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum circumsporozoite protein (PfCSP) central repeat region is the immunodominant domain of the major surface protein found on the sporozoite stage of the malaria parasite (UniProt: P19597). This region consists of multiple tandem repeats of the amino acid sequence NANP (asparagine-alanine-asparagine-proline), interspersed with a small number of NVDP motifs. Biologically, this region is essential for the parasite's transition from the mosquito vector to the human host, facilitating sporozoite migration through the dermis and the subsequent invasion of liver cells (Nature, 2018). It is the primary target for the most advanced malaria vaccines, including RTS,S/AS01 (Mosquirix) and R21/Matrix-M, which are designed to elicit high levels of antibodies that neutralize the parasite before it can establish a productive infection (WHO, 2023). These antibodies bind to the repeats and prevent the sporozoite from entering hepatocytes, effectively blocking the life cycle before the symptomatic blood stage begins. Additionally, the central repeat region is a major focus for the development of next-generation monoclonal antibodies intended for passive immunization and long-term prophylaxis (Science, 2020). Despite its relative conservation across different parasite strains, the primary challenge in targeting this region is the necessity of maintaining exceptionally high antibody titers to ensure sterile protection against infection.
Induction of neutralizing antibodies that bind to the NANP repeats, sterically hindering sporozoite motility and blocking the interaction with host hepatocyte receptors, thereby preventing liver-stage infection (The Lancet, 2021; Science, 2020).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum circumsporozoite protein central repeat region (PfCSP central repeat region).